Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Clin Invest Med ; 39(6): 27511, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27917801

ABSTRACT

PURPOSE: The purpose of this study was to evaluate the efficacy of Ginkgo biloba extract (EGb 761) on oxidative events of brain in cisplatin-administrated rats. METHODS: Rats were divided into four experimental groups: 1) control (n=6); 2) cisplatin (8 mg/kg, intraperitoneally one dose, n=6); 3) EGb 761 (100 mg/kg intraperitoneally for 15 days, n=6); and 4) cisplatin + EGb 761 (n=6). After drug administration, rats were sacrificed and brain tissues were removed. Nitric oxide (NO), malondialdehyde (MDA) and glutathione (GSH) levels were evaluated in brain tissues. RESULTS: Single dose cisplatin administration significantly increased NO and GSH levels, but decreased MDA levels in brain tissue samples. EGb 761 treatment reversed the effects of cisplatin on NO and GSH levels, but did not affect the decreased MDA levels. CONCLUSION: Results of the study indicate that oxidative stress can be an important pathogenetic mechanism of cisplatin-induced neurotoxicity. EGb 761, an standardized extract of G. biloba leaves that has antioxidant properties, may improve the oxidative stress-related neurological side effects of cisplatin.


Subject(s)
Brain/metabolism , Cisplatin/pharmacology , Ginkgo biloba/chemistry , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Animals , Brain Chemistry/drug effects , Female , Glutathione/metabolism , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Plant Extracts/chemistry , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL